F-18 FDG uptake by recurrent Hurthle cell carcinoma of the thyroid using high-energy planar scintigraphy

Clinical Nuclear Medicine

Volumn 21, Issue 11, 1996, Pages 831-833

  Blount, Cynthia L ^a   Dworkin, Howard J ^a,b  

^a Willaim Beaumont Hospital   (United States)

^b WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IODINE; IODINE 131; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; STEROID; THYROGLOBULIN; THYROID HORMONE; THYROXINE;

ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; MALE; ORAL DRUG ADMINISTRATION; POSITRON EMISSION TOMOGRAPHY; THYROID CARCINOMA; THYROID SCINTISCANNING; THYROIDECTOMY;

ADENOCARCINOMA; DEOXYGLUCOSE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; GAMMA CAMERAS; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OBESITY, MORBID; TECHNETIUM TC 99M SESTAMIBI; THYROID NEOPLASMS;

EID: 0029903558     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-199611000-00001     Document Type: Article

References (9)

1. Adler LP, Bloom AD: Positron emission tomography of thyroid masses. Thyroid 3:195, 1993.
2. Hawkins RA, Hoh C, Glaspy J, et al: The role of positron emission tomography in oncology and other whole-body applications. Semin Nucl Med 4:268, 1992.
3. McLeod MK, Thompson NW: Hürthle cell neoplasms of the thyroid. Otolaryngeal Clin North Am 23:441, 1990.
4. Mazzaferri EL: Thyroid Cancer In: Becker KL (ed). Principles and Practice of Endocrinology and Metabolism. Philadephia, J.B. Lippincott 1990, pp. 319-331.
5. Har-el G, Hadar T, Segal K, et al: Hürthle cell carcinoma of the thyroid gland. A tumor of moderate malignancy. Cancer 57: 1613, 1986.
6. Tollefsen HR, Shah JP, Huros AG: Hürthle cell carcinoma of the thyroid. Am J Surg 130:390, 1975.
7. Abdel-Nabi H, Hinkle GH, Falko JM, et al: Iodine-131-labeled anti-CEA antibodies uptake by Hürthle cell carcinoma. Clin Nucl Med 10:713, 1985.
8. Tzu-Chen Y, Hong-Dar L, Chen-Hsen L, et al: The role of technetium-99m sestamibi whole-body scans in diagnosing metastatic Hürthle cell carcinoma of the thyroid gland and after total thyroidectomy: a comparison with Iodine-131 and thallium-201 whole body scans. Eur J Nucl Med 21:980, 1994.
9. Balon HR, Fink-Bennett D, Stoffer S: Technetium-99m-sestamibi uptake by recurrent Hürthle Cell Carcinoma of the Thyroid. J Nucl Med 33:1393, 1992.